Essex Investment Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.19M | Sell |
617,299
-4,413
| -0.7% | -$51.4K | 1.31% | 12 |
|
|
2025
Q1 | $4.62M | Sell |
621,712
-4,126
| -0.7% | -$30.7K | 0.96% | 21 |
|
|
2024
Q4 | $3.75M | Sell |
625,838
-92,818
| -13% | -$556K | 0.67% | 47 |
|
|
2024
Q3 | $3.68M | Buy |
718,656
+94,831
| +15% | +$486K | 0.64% | 57 |
|
|
2024
Q2 | $2.26M | Buy |
623,825
+346,729
| +125% | +$1.26M | 0.42% | 96 |
|
|
2024
Q1 | $889K | Buy |
277,096
+5,183
| +2% | +$16.6K | 0.18% | 148 |
|
|
2023
Q4 | $1.33M | Buy |
271,913
+61,693
| +29% | +$302K | 0.26% | 136 |
|
|
2023
Q3 | $1.15M | Sell |
210,220
-1,486
| -0.7% | -$8.1K | 0.19% | 173 |
|
|
2023
Q2 | $1.42M | Buy |
211,706
+31,134
| +17% | +$209K | 0.2% | 160 |
|
|
2023
Q1 | $1.59M | Buy |
+180,572
| New | +$1.59M | 0.23% | 138 |
|